Zimmer Biomet Holdings (ZBH) Operating Expenses (2009 - 2026)

Zimmer Biomet Holdings has reported Operating Expenses for 18 years, with the latest figure at $1.9 billion in Q2 2026.

• On a quarterly basis, Operating Expenses rose 4.14% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $7.3 billion, a 11.12% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 11.58% from the prior year.
• Operating Expenses was $1.9 billion for Q2 2026 at Zimmer Biomet Holdings, up from $1.7 billion in the prior quarter.
• The five-year high for Operating Expenses was $2.1 billion in Q4 2025, with the low at $1.4 billion in Q3 2022.
• Average Operating Expenses over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses declined 14.43% in 2023, then grew 27.84% in 2025.
• Over 5 years, Operating Expenses stood at $1.9 billion in 2022, then fell by 14.43% to $1.6 billion in 2023, then increased by 3.05% to $1.6 billion in 2024, then climbed by 27.84% to $2.1 billion in 2025, then retreated by 11.41% to $1.9 billion in 2026.
• The last three Operating Expenses figures came in at $1.9 billion (Q2 2026), $1.7 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.